Cara Therapeutics Announces Presentations at Kidney Week 2019

Posted by Invest In Weed | Nov 1, 2019 | Biomedical, Conferences, US Stocks | 3

Late-breaking oral presentation to highlight data from KALM-1 pivotal Phase 3 trial of KORSUVA™ Injection in hemodialysis patients with pruritus.

0 0 votes

Article Rating

3 Comments

Oldest

Newest Most Voted

Inline Feedbacks

View all comments

binance open account

1 year ago

Thanks for sharing. I read many of your blog posts, cool, your blog is very good. https://accounts.binance.com/bn/register?ref=UM6SMJM3

0

7 months ago

Can you be more specific about the content of your article? After reading it, I still have some doubts. Hope you can help me.

0

Регистрация на binance

2 months ago

Your point of view caught my eye and was very interesting. Thanks. I have a question for you. https://accounts.binance.com/sl/register?ref=I3OM7SCZ

0

Invest In Weed TV

GET LISTED

Invest In Weed - Get Listed, List your business

News Highlights

Silly Mistakes to Avoid When Purchasing Cannabis Equipment February 13, 2022
What Kind Of Cannabis Seeds To Buy October 28, 2021
What Are Auto-Flowering Cannabis Seeds October 27, 2021
How Long Does It Take Cannabis Seeds To Germinate October 19, 2021
How To Get A License To Grow Cannabis In California August 30, 2021
Stages of the Cannabis Plant Growth Cycle April 19, 2024
Future Farm Prepares Maine-Grown Hemp Biomass and Seeds for Processing and Market November 25, 2019
Auxly Announces Outdoor Cultivation Expansion Through the Launch of Robinsons Outdoor Grow November 18, 2019

Join Our Newsletter

Get stock alerts, news & related alerts straight to your inbox!

No Fields Found.

3

0

Would love your thoughts, please comment.x

()